Cargando…

Pasireotide and octreotide in the treatment of severe late dumping syndrome

Hypoglycemia due to late dumping is a significant problem postoesophagectomy but may not always be diagnosed sufficiently early. It can be difficult to treat and may severely compromise quality of life. The combination of diazoxide and octreotide or more probably pasireotide may transform the patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohammadi, Alireza, Sulaiman, Raashda A., Grossman, Ashley B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5628213/
https://www.ncbi.nlm.nih.gov/pubmed/29026555
http://dx.doi.org/10.1002/ccr3.1025
_version_ 1783268836939661312
author Mohammadi, Alireza
Sulaiman, Raashda A.
Grossman, Ashley B.
author_facet Mohammadi, Alireza
Sulaiman, Raashda A.
Grossman, Ashley B.
author_sort Mohammadi, Alireza
collection PubMed
description Hypoglycemia due to late dumping is a significant problem postoesophagectomy but may not always be diagnosed sufficiently early. It can be difficult to treat and may severely compromise quality of life. The combination of diazoxide and octreotide or more probably pasireotide may transform the patient's life and should be considered in all problematic cases.
format Online
Article
Text
id pubmed-5628213
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-56282132017-10-12 Pasireotide and octreotide in the treatment of severe late dumping syndrome Mohammadi, Alireza Sulaiman, Raashda A. Grossman, Ashley B. Clin Case Rep Case Reports Hypoglycemia due to late dumping is a significant problem postoesophagectomy but may not always be diagnosed sufficiently early. It can be difficult to treat and may severely compromise quality of life. The combination of diazoxide and octreotide or more probably pasireotide may transform the patient's life and should be considered in all problematic cases. John Wiley and Sons Inc. 2017-08-22 /pmc/articles/PMC5628213/ /pubmed/29026555 http://dx.doi.org/10.1002/ccr3.1025 Text en © 2017 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Reports
Mohammadi, Alireza
Sulaiman, Raashda A.
Grossman, Ashley B.
Pasireotide and octreotide in the treatment of severe late dumping syndrome
title Pasireotide and octreotide in the treatment of severe late dumping syndrome
title_full Pasireotide and octreotide in the treatment of severe late dumping syndrome
title_fullStr Pasireotide and octreotide in the treatment of severe late dumping syndrome
title_full_unstemmed Pasireotide and octreotide in the treatment of severe late dumping syndrome
title_short Pasireotide and octreotide in the treatment of severe late dumping syndrome
title_sort pasireotide and octreotide in the treatment of severe late dumping syndrome
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5628213/
https://www.ncbi.nlm.nih.gov/pubmed/29026555
http://dx.doi.org/10.1002/ccr3.1025
work_keys_str_mv AT mohammadialireza pasireotideandoctreotideinthetreatmentofseverelatedumpingsyndrome
AT sulaimanraashdaa pasireotideandoctreotideinthetreatmentofseverelatedumpingsyndrome
AT grossmanashleyb pasireotideandoctreotideinthetreatmentofseverelatedumpingsyndrome